Development
Sarepta Therapeutics, Inc.
SRPT
$16.26
-$0.49-2.93%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.74% | -16.35% | -3.49% | -6.52% | -5.98% |
| Total Receivables | 68.08% | 58.54% | 16.02% | 46.08% | 52.41% |
| Inventory | 58.29% | 10.32% | 9.03% | 1.85% | 9.54% |
| Prepaid Expenses | 1.72% | 11.21% | 16.08% | 4.44% | -2.21% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 50.61% | 8.85% | 14.07% | -7.48% | -26.77% |
| Total Current Assets | 0.84% | -6.67% | 0.13% | -1.68% | -1.78% |
|
|
|||||
| Total Current Assets | 0.84% | -6.67% | 0.13% | -1.68% | -1.78% |
| Net Property, Plant & Equipment | 45.76% | 54.36% | 40.52% | 4.99% | 3.51% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 290.87% | 49.35% | 37.94% | -45.99% | -46.78% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.88% | 10.06% | 11.83% | 17.56% | 11.07% |
| Total Assets | 4.35% | -1.47% | 4.31% | 0.12% | -0.62% |
|
|
|||||
| Total Accounts Payable | 72.01% | -25.76% | 95.34% | 97.59% | 24.93% |
| Total Accrued Expenses | -40.39% | -31.34% | -28.82% | 13.76% | 62.59% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 696.23% | -31.52% | 3.51% | -2.37% | -- |
| Total Finance Division Other Current Liabilities | -4.19% | -12.82% | -7.40% | -0.63% | 1.78% |
| Total Other Current Liabilities | -4.19% | -12.82% | -7.40% | -0.63% | 1.78% |
| Total Current Liabilities | 5.50% | -25.24% | -8.60% | 18.01% | 36.86% |
|
|
|||||
| Total Current Liabilities | 5.50% | -25.24% | -8.60% | 18.01% | 36.86% |
| Long-Term Debt | -26.66% | -19.84% | 12.23% | 12.33% | 40.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 144.82% | 282.50% | 228.11% | 39.65% | 38.70% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.40% | -3.91% | -10.85% | -13.99% | -17.00% |
| Total Liabilities | -12.33% | -13.94% | 5.02% | 6.72% | 23.58% |
|
|
|||||
| Common Stock & APIC | 23.45% | 24.13% | 21.56% | 23.30% | 3.92% |
| Retained Earnings | -13.71% | -18.18% | -25.62% | -33.67% | -21.94% |
| Treasury Stock & Other | 155.17% | 80.09% | 57.55% | -36.93% | -8,220.00% |
| Total Common Equity | 123.23% | 77.41% | 2.06% | -16.82% | -58.52% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 123.23% | 77.41% | 2.06% | -16.82% | -58.52% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 123.23% | 77.41% | 2.06% | -16.82% | -58.52% |
|
|
|||||